Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.800
+0.085 (4.96%)
At close: Dec 20, 2024, 4:00 PM
1.780
-0.020 (-1.11%)
After-hours: Dec 20, 2024, 5:52 PM EST

Milestone Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Net Income
-42.77-59.69-58.39-42.85-49.97-55.23
Upgrade
Depreciation & Amortization
0.610.60.480.360.380.24
Upgrade
Other Amortization
0.360.24----
Upgrade
Loss (Gain) From Sale of Assets
0.01-0.14---
Upgrade
Loss (Gain) From Sale of Investments
-0.42-0.16-0.1---
Upgrade
Stock-Based Compensation
6.189.539.057.284.951.19
Upgrade
Other Operating Activities
2.661.8-0.39-0.27-0.28-0.2
Upgrade
Change in Accounts Receivable
0.31-2.33-0.760.10.040.12
Upgrade
Change in Accounts Payable
-2.911.04-0.910.64-2.083.52
Upgrade
Change in Income Taxes
------0.06
Upgrade
Change in Other Net Operating Assets
4.172.53-1.61.52-3.76-0.74
Upgrade
Operating Cash Flow
-31.8-46.42-52.47-33.22-50.73-51.15
Upgrade
Capital Expenditures
-0.04-0.11-0.27---0.41
Upgrade
Investment in Securities
2.674.87-56.8570-700.03
Upgrade
Investing Cash Flow
2.634.76-57.1270-70-0.38
Upgrade
Long-Term Debt Issued
-50----
Upgrade
Net Debt Issued (Repaid)
-50----
Upgrade
Issuance of Common Stock
27.480.583.090.1225.2285.41
Upgrade
Other Financing Activities
4.62-2.79-4.9348.01-
Upgrade
Financing Cash Flow
32.147.793.095.0673.2285.41
Upgrade
Net Cash Flow
2.926.12-106.5141.83-47.5133.87
Upgrade
Free Cash Flow
-31.84-46.54-52.74-33.22-50.73-51.57
Upgrade
Free Cash Flow Margin
--4653.60%-1054.82%-221.49%--
Upgrade
Free Cash Flow Per Share
-0.56-1.08-1.24-0.79-1.73-3.27
Upgrade
Levered Free Cash Flow
-20.74-28.29-31.36-17.05-32.15-32.3
Upgrade
Unlevered Free Cash Flow
-18.9-26.94-31.36-17.05-32.15-32.3
Upgrade
Change in Net Working Capital
-1.57-1.233.34-2.235.78-2.86
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.